Entest BioMedical Inc. (ENTB) Stock Continues Rally in Today’s Morning Session
Shares of Entest BioMedical Inc. (PINK: ENTB), a biotechnology company engaged in the development of stem cell therapy treatments for chronic obstructive pulmonary disease, are continuing its rally in today’s trading.
At last check, the penny stock of ENTB was trading 19.33% higher at $0.0179, with volume up from daily average of 5.98 million to 9.49 million. The stock gained 184.62% in the last three trading sessions.
A recent 8K filing made by Entest BioMedical showed that the company signed an Equity Purchase Agreement with Southridge Partners II, L.P. under which Southridge will purchase up to $10 million of ENTB’s registered common stock. The purchase will be made at ENTB’s election. The purchase price for the shares will be equal to 91% of the average of the two lowest closing prices during the valuation period.
- This newsletter has been helping traders make a killing on ENTB. Click here for a 25% discount offer.
- See today’s top stock picks and market analysis
- Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
- Want more? Check out the message board buzz for ENTB
- See what newsletters are recommending this stock pick
- Get breaking news alerts on these stocks: http://thestockmarketwatch.com/
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Tech24.org is a wholly-owned subsidiary of BlueWave Advisors.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.